Founded in 1936, União Química is one of Brazil’s largest and most robust pharmaceutical companies. The IFC loan will be used to further the expansion of União Química’s production capacity, vaccine infrastructure and energy efficiency projects. This will be achieved by directing funds towards the modernisation of the company’s plants and the boosting of its production capacity for vaccines and medicines, furthering União Química’s goal to join the international vaccination system and offer immunisers to Latin American nations.

The Becker Glynn team was led by partner Peter Hosinski and associate Tianpu Zhang, who (along with other firm members) addressed, inter alia, the drafting intricacies related to a real-denominated loan that was repayable in dollar-equivalent amounts.